Effect of Patient Position on Bupivacaine Dose Requirement and Hemodynamic Stability in Spinal Anesthesia

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorUniversity of Health Sciences Balikesir Hospital Eduation and Research

About this trial

This study compares different combinations of local anesthetic doses and patient positions during spinal anesthesia for urogenital surgery. Spinal anesthesia is a common and safe technique where medication is injected into the lower back to numb the body during surgery.

The study will test two different doses of bupivacaine (a numbing medication): a lower dose (8 mg) and a standard dose (12 mg). It will also test two different patient positions after the spinal injection: lying flat (neutral position) and lying with the head slightly lower than the feet (Trendelenburg position).

Participants will be randomly assigned to one of four groups:

* Group 1: Lower dose + lying flat * Group 2: Lower dose + head-down position * Group 3: Standard dose + lying flat * Group 4: Standard dose + head-down position

The study will measure how well the anesthesia works, how high the numbness spreads in the body, and how it affects blood pressure and heart rate. The goal is to find the best combination of dose and position that provides good anesthesia while keeping blood pressure stable.

This research may help doctors choose the safest and most effective anesthesia approach for each patient based on their individual needs.

Eligibility criteria

Qualifiers

Age 18-70 years

American Society of Anesthesiologists (ASA) physical status classification I-II

Scheduled for elective urogenital surgery

Suitable candidate for spinal anesthesia

Disqualifiers

Contraindications to spinal anesthesia (coagulopathy, infection at injection site, patient refusal)

History of neurological disease

Spinal deformity or previous spinal surgery

History of allergic reaction to local anesthetics (amide-type)

Trial design

Treatments tested in this trial

  • Bupivacaine %0.5 (hyperbaric)

Treatment groups

100 Participants
are divided into 4 treatment groups

Locations

This trial has no locations